These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37201191)

  • 1. Differential biventricular adaption to pulmonary vascular disease in patients with idiopathic/heritable and congenital heart disease: a prospective cardiac magnetic resonance and invasive study.
    Xu Z; Dou R; Zhou Z; Zhang H; Zhang C; Li Q; Xu L; Gu H
    Eur Heart J Cardiovasc Imaging; 2023 Oct; 24(11):1528-1535. PubMed ID: 37201191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial Hypertension.
    Haarman MG; Coenraad I; Hagdorn QAJ; Hillege HL; Willems TP; Berger RMF; Douwes JM
    Children (Basel); 2023 Apr; 10(4):. PubMed ID: 37190005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension.
    Liu D; Wu BX; Sun N; Yan Y; Yuan P; Qu JM; Jing ZC
    Chest; 2016 Aug; 150(2):367-73. PubMed ID: 27001265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Hsu S; Houston BA; Tampakakis E; Bacher AC; Rhodes PS; Mathai SC; Damico RL; Kolb TM; Hummers LK; Shah AA; McMahan Z; Corona-Villalobos CP; Zimmerman SL; Wigley FM; Hassoun PM; Kass DA; Tedford RJ
    Circulation; 2016 Jun; 133(24):2413-22. PubMed ID: 27169739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
    Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of right ventricular ejection/filling parameters in IPAH using cardiac magnetic resonance: A prospective pilot study.
    Li W; Yang T; Zhang Y; Gu Q; Liu ZH; Ni XH; Luo Q; Xiong CM; He JG
    Respirology; 2017 Jan; 22(1):172-178. PubMed ID: 27442028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential serum lipid distribution in IPAH and CHD-PAH patients.
    Chen J; Rathinasabapathy A; Luo J; Yang X; Luo P; Chen Y; Li Z; Li J
    Respir Med; 2022 Jan; 191():106711. PubMed ID: 34890866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
    Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.
    Austin ED; Menon S; Hemnes AR; Robinson LR; Talati M; Fox KL; Cogan JD; Hamid R; Hedges LK; Robbins I; Lane K; Newman JH; Loyd JE; West J
    Pulm Circ; 2011; 1(3):389-98. PubMed ID: 22140629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension.
    Zhang Y; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Li X; An C; Ma X; Xiong C; Luo Q; Liu Z
    Clin Exp Rheumatol; 2021; 39(5):1063-1070. PubMed ID: 33200733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.
    Pfarr N; Fischer C; Ehlken N; Becker-Grünig T; López-González V; Gorenflo M; Hager A; Hinderhofer K; Miera O; Nagel C; Schranz D; Grünig E
    Respir Res; 2013 Jan; 14(1):3. PubMed ID: 23298310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.